The Galaxy NotePRO 12.2 is Here and The Snugg Have it Covered!

The newest and most impressive Samsung Galaxy Note is here and case manufacturer The Snugg already have a range of cases available.

2014-04-24

TAMPA, FL, April 24, 2014 (Press-News.org) Samsung has released its most powerful tablet for business users yet - the Galaxy NotePRO 12.2. The massive 12.2-inch slab is already proving popular with professionals, and tablet case makers The Snugg have just released a range of covers to protect the high-end device from damage. The folio-style cases are made from resilient PU leather to keep the Galaxy NotePRO 12.2 free from knocks and bumps.

With its 12.2-inch display at a gorgeous 1600 x 2560 resolution, the Galaxy NotePRO 12.2 is ideal for viewing documents and watching films. The tablet is powered by 1.9GHz Quad + 1.3GHz Quad processing chips to provide extra drive and with the 9500mAh battery, you'll be able to keep using your device for longer.

The Galaxy NotePRO 12.2 has Samsung's inbuilt stylus S Pen, bringing with it a host of new features. Users can try out Air Command: a way to access great features just by hovering the S Pen over the Galaxy NotePRO's screen. Take notes using the Action Memo app and then call any numbers or search any addresses that have been written down. For anyone quickly wanting to add annotations, users can simply take a screenshot and use the Screen Write feature to doodle on it before sharing it with friends.

For those using the Galaxy NotePRO 12.2 for business, the tablet comes with a handy way to multitask. The Multi Window feature allows four windows or apps to be open at once, meaning it's easy to work on documents while you browse online or play on games.

The tablet's back is covered in an attractive leather-style material, offering something a bit different from the standard plastic. However, this means it can be more easily scratched, so keeping it protected is a real priority.

Les Yates, marketing manager at The Snugg, said: "Customers love the display of the Galaxy NotePRO 12.2, as it's perfect for viewing A4 documents or reading magazines. However, its larger size makes it tricky to hold with one hand and can lead to it getting dropped.

"That's why we at The Snugg have created a range of NotePRO cases, specifically designed to keep the Samsung tablet looking as good as new and free from scuffs and scratches. The NotePRO 12.2 is a premium tablet and we think it deserves premium protection."

ELSE PRESS RELEASES FROM THIS DATE:

Altys Group, Exclusive Distributor of ForaCare Suisse AG Products in South Africa, Launches the FORA Diamond MINI Blood Glucose Monitor in Partnership with Discovery Health

2014-04-24

Altys Group announced the launch of the ForaCare Suisse AG FORA Diamond MINI blood glucose monitor in South Africa. An exclusive distributor of ForaCare since 2013, Altys Group has partnered with Discovery Health, which manages South Africa's largest open medical scheme and 13 closed schemes, to offer the Diamond MINI to all Discovery Health Medical Scheme members excluding members of Keycare plans. Eligible members can receive a free Diamond MINI from MedXpress and Dis-Chem stores as part of a diabetes care program. The FORA Diamond MINI blood glucose monitor is a leading ...

Great Minds in STEM and U.S. Department of Defense Present "Sneak Peek" Event

2014-04-24

Great Minds in STEM (GMiS), in conjunction with the U.S. Department of Defense (DoD), will proudly showcase a Viva Technology Program during the 3rd USA Science and Engineering Festival Sneak Peek Friday, on April 25, 2014. The Viva Technology, GMiS flagship K-12 STEM awareness program, will host 160 Washington D.C.students from Howard University Middle School and McKinley Technology Center. This special event themed, Celebrate Diversity in STEM!, will be held at the Walter E. Washington Convention Center, in Washington D.C. Students will experience STEM project-based ...

Eating Sugar Doubles Risk of Death in Cancer Patients, According to Nature Works Best's Groundbreaking Study

2014-04-24

A seven-year study of cancer patients, by Dr. Colleen Huber, NMD and her team at Nature Works Best, an alternative cancer clinic in Tempe, Arizona, exposes a severe threat to the survival of cancer patients - the consumption of sweetened food or drink. Dr. Huber led a team of physicians in a seven-year study where cancer patients avoided all types of sugar, including honey, maple syrup, corn syrup, high fructose corn syrup, plant nectars, alcohol and fruit juices. This is the first large, human, interventional study that has indicted sugar as deadly for cancer patients. ...

Rabbit TV Announces Launch of Streaming Live TV Channels Amidst Aereo Controversy

2014-04-24

As Aereo defends its live TV streaming service in front of the Supreme Court, Rabbit TV today announced a similar feature added to its popular eMedia guide, giving its 3 million+ users easy access to nearly 100 live TV stations over the web, including popular US stations like The CW, PBS, Ion, Univision, Telemundo, This, and MeTV, to name a few. The offering also incorporates international channels like Eurosport, RT, and ZDF, along with popular news, shopping and variety channels such as Bloomberg, MSNBC, QVC, HSN, and various others. The twist is that all of these channels ...

Play2Shop.com: Website Combines Free Casual Gaming With Innovative Cash Back Shopping and Unique Fundraising Opportunities

2014-04-24

Play2Shop.com is the first online community that has taken the "free" casual gaming experience to a whole new level - giving its members fun and novel ways to earn free rewards, buy goods, win auction items and even raise money for great charities! "Retailers are drawn to Play2Shop.com because of its unique shopping and free casual gaming platform that drives traffic, engages and entertains user's, builds brand loyalty, and most of all, helps drive sales back to our merchant partners!" said John Benton, Play2Shop.com's CEO. "Members love Play2Shop.com because of our ...

Use of frozen material for fecal transplant successfully treats C. difficile infection

2014-04-24

A pilot study by Massachusetts General Hospital (MGH) investigators may lead to greater availability and acceptability of an unusual treatment for a serious medical problem – use of fecal material from healthy donors to treat recurrent diarrhea caused by the Clostridium difficile (C. difficile) bacteria. In their paper being published online in the journal Clinical Infectious Diseases, the researchers report that use of prescreened frozen fecal material from donors unrelated to patients was as successful in curing recurrent C. difficile infection as was the use of fresh ...

Pilot study suggests ways to widen access to fecal transplants for C. diff infections

2014-04-24

Using frozen stool from healthy, unrelated donors was safe and effective in treating patients with serious, relapsing diarrhea caused by Clostridium difficile, according to a new pilot study published in Clinical Infectious Diseases and available online. Known as fecal microbiota transplantation, the treatment was equally effective whether given via a colonoscope or a nasogastric tube. The findings suggest approaches that may make this promising treatment more readily available to patients. A growing concern, C. difficile causes 250,000 infections requiring hospitalization ...

Pregnancy complications may be more common in immigrants from certain regions

2014-04-24

TORONTO, April 24, 2014 – Pregnant immigrants from Sub-Saharan Africa, Latin America and Caribbean islands may require increased monitoring during pregnancy, according to new research from St. Michael's Hospital. The study, published today in the British Journal of Obstetrics and Gynaecology, assessed the differences in preeclampsia and eclampsia rates among immigrants and native-born women in six high-immigration countries – Australia (Victoria), Canada (Ontario), Denmark, Sweden, Spain (Catalonia and Valencia) and the United States (California, New Jersey and New York ...

Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia

2014-04-24

Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising. Patients treated with CPX-351, a combination of the chemotherapeutic drugs cytarabine and daunorubicin, are showing better responses than patients treated with the standard drug formulation. "Acute myeloid leukemia is an aggressive blood cancer with very low rates of treatment success, especially in older patients," explained Jeffrey Lancet, M.D., senior member of the Department of Malignant Hematology and chief of the Leukemia ...

It's a bubble, but not as we know it

2014-04-24

Multi-sensory technology that creates soap bubbles, which can have images projected onto them or when the bubbles are burst release a scent, will be unveiled at an international conference later this month. The research paper, to be presented at one of the world's most important conferences on human-computer interfaces - ACM CHI 2014 [26 April-1 May], could be used in areas such as gaming or education and encourage a new way of thinking about multi-sensory technologies. SensaBubble, led by Professor Sriram Subramanian from the University of Bristol's Department of ...

The Galaxy NotePRO 12.2 is Here and The Snugg Have it Covered!

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: